Objective: The purpose of this study was to test the effect of patient involvement levels, developed using different breast cancer risk scenarios and message format on their intention to initiate breast cancer chemoprevention. Method: In this experimental field study involvement was manipulated at 2 levels (high and low) and was developed using two scenarios. Breast cancer risk levels were considered using the Gail risk score. A breast cancer risk level of 16% with family history was used for low risk scenario and breast cancer risk level of 55% with family history and a breast biopsy was used for high risk scenario. Message format was manipulated 2 levels (graphic and written) and was developed using concepts of chunking and picture super...
Background: Chemoprevention for women at elevated risk of breast cancer is endorsed by international...
The literature on risk perception in women from high-risk breast cancer families reveals persistent ...
Introduction: Tamoxifen and raloxifene are chemopreventive drugs that can reduce women's relative ri...
There is significant interest in developing chemoprevention trials for women at high risk for breast...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
OBJECTIVE: This study was conducted to explore the possible influence of risk notification regarding...
International audienceIt has been shown in several studies that antihormonal compounds can offer eff...
Objectives: 1) To describe how women at high-risk for breast cancer (BC) perceive their at-risk stat...
Abstract Background Breast cancer chemoprevention can reduce breast cancer incidence in high-risk wo...
OBJECTIVES: The study aim is to describe interest in breast cancer chemoprevention among older women...
Guidelines endorse the use of chemoprevention for breast cancer risk reduction. This study examined ...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
RATIONALE AND OBJECTIVES: Performing breast cancer risk assessment at the time of screening mammogra...
This study was designed to examine and explain the use of risk-reducing behaviors in a group of wome...
Introduction: Breast cancer incidence starts to increase exponentially when women reach 30-39 years...
Background: Chemoprevention for women at elevated risk of breast cancer is endorsed by international...
The literature on risk perception in women from high-risk breast cancer families reveals persistent ...
Introduction: Tamoxifen and raloxifene are chemopreventive drugs that can reduce women's relative ri...
There is significant interest in developing chemoprevention trials for women at high risk for breast...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
OBJECTIVE: This study was conducted to explore the possible influence of risk notification regarding...
International audienceIt has been shown in several studies that antihormonal compounds can offer eff...
Objectives: 1) To describe how women at high-risk for breast cancer (BC) perceive their at-risk stat...
Abstract Background Breast cancer chemoprevention can reduce breast cancer incidence in high-risk wo...
OBJECTIVES: The study aim is to describe interest in breast cancer chemoprevention among older women...
Guidelines endorse the use of chemoprevention for breast cancer risk reduction. This study examined ...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
RATIONALE AND OBJECTIVES: Performing breast cancer risk assessment at the time of screening mammogra...
This study was designed to examine and explain the use of risk-reducing behaviors in a group of wome...
Introduction: Breast cancer incidence starts to increase exponentially when women reach 30-39 years...
Background: Chemoprevention for women at elevated risk of breast cancer is endorsed by international...
The literature on risk perception in women from high-risk breast cancer families reveals persistent ...
Introduction: Tamoxifen and raloxifene are chemopreventive drugs that can reduce women's relative ri...